Log in or Sign up for Free to view tailored content for your specialty!
Pediatric Dermatology News
Infants with atopic dermatitis, high-risk factors more likely to experience atopic march
Severe disease, male sex, family history and prenatal factors were significantly associated with an increased risk for atopic march progression in infants with atopic dermatitis, according to a study.
Long-term follow-up in anogenital lichen sclerosus needed to prevent morbidities
Anogenital lichen sclerosus can lead to permanent anatomical changes and sexual discomfort in women, highlighting a need for long-term follow-up and high treatment adherence, the latter of which is lacking, according to a study.
Pediatric dermatologists positioned to educate children, parents on female anatomy
Pediatric dermatologists are well positioned to educate children and adults on the correct terms for female anatomy to ensure proper diagnoses and treatments, according to a study.
Log in or Sign up for Free to view tailored content for your specialty!
Healio compiles top pediatric dermatology articles of 2024
As 2024 comes to a close, Healio has assembled this year’s most-read pediatric dermatology articles.
Arcutis submits sNDA for Zoryve cream 0.05% to treat AD in children aged 2 to 5 years
Arcutis Biotherapeutics has submitted a supplemental new drug application to the FDA for Zoryve cream 0.05% for the treatment of pediatric mild to moderate atopic dermatitis, according to a press release.
Healthy boy with sore on left lower eyelid
A healthy 5-year-old boy, whose only problem had been mild-to-moderate seborrheic dermatitis, is taken to his provider with the complaint of a sore on his left lower eyelid.
Beneath the Surface: Investigating dupilumab’s use in pediatric alopecia areata treatment
Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio cDermatology Chief Medical Editor, discusses hot topics in the field with leading experts.
Infantile hemangiomas thicker with steeper borders in preterm infants
Preterm infants more often presented with infantile hemangiomas that were thicker with steeper borders compared with term infants, signaling a need for improved treatment, according to a study.
Johnson & Johnson submits sBLAs for Tremfya for two pediatric indications
Johnson & Johnson has submitted two supplemental biologics license applications to the FDA for Tremfya for the treatment of plaque psoriasis and juvenile psoriatic arthritis in children, the company announced in a press release.
Exclusive interview on 2025 physician fee schedule cuts leads November dermatology news
An in-depth interview about the effects of the CMS’s 2025 physician fee schedule on patient access topped Healio Dermatology’s most-read articles of November, with FDA news also garnering attention.
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read